This lack of correlation between MMR dysfunction and MSI could be due to involvement of MMR genes not leading to MSI formation like MLH6 or PMS2.Thus in breast cancers immunohistochemistry for MMR protein products would appear to be more logical for detection of loss of MMR function [9-16]. Here, PMS2 is linked to breast cancer.